Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach and ...

CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutical processing, today announced the launch of its new MicroCNX® ...

Every time a shuttle docks with the International Space Station (ISS), a precise and intricate process takes place between ...

In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...

As CTO, Mr. Beneski will oversee Allogene's technical operations, leveraging his extensive expertise in biologics ...

Beijing has released New Market Access Updates, as China is significantly opening its economy to foreign investment across ...

However, significant barriers stand in the way of realising this promise on a worldwide scale, from manufacturing costs and ...

Scientists have discovered a potential new treatment for familial hypercholesterolemia, inspired by signs seen in the Mona ...

Mahidol University, in collaboration with the Mahidol University Foundation under the Royal Patronage of Her Royal Highness ...

Top-line Phase 3 trial data show ambulatory boys with Duchenne continued with motor improvements two years after a single Elevidys infusion.

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.